Deals, joint ventures & alliances

NDR Medical raises $8 mil in Series A funding; prepares for expansion into US

Singapore-based surgical robotic firm NDR Medical Technology (NDR) has secured $8 million in its Series A funding on Monday.


OUE Lippo Healthcare JV to manage 3 hospitals in major Chinese cities

SINGAPORE (Dec 31): OUE Lippo Healthcare will manage three medical facilities in Shanghai, Chongqing and Nanjing through to a joint-venture agreement.

Indonesia billionaire family reshuffles empire on currency rout

SINGAPORE/JAKARTA (Sept 19): Southeast Asia’s billionaire Riady family is reshuffling its health-care holdings as its core property business grapples with the emerging-market rout.


Time needed to heal TalkMed's wound from CEO Ang's suspension: RHB

SINGAPORE (Apr 27): RHB is maintaining its “neutral” call on TalkMed Group with a lower target price of 70 cents from 72 cents previously after the group reported a weak 1Q18 set of financial results.  

Broker's Calls

Tianjin Zhongxin Pharma on its way to a stellar 2018 & beyond, says UOB

SINGAPORE (Apr 2): UOB Kay Hian is keeping Tianjin Zhongxin Pharmaceutical Group at “buy” with a higher target price of US$1.66 ($2.17), pegged to peer average of 14.1 times FY18 earnings.


More acquisitions likely for Singapore Medical Group in 2018

SINGAPORE (Mar 1): UOB Kay Hian is maintaining its “buy” call on Singapore Medical Group (SMG) with a P/E-based target price of 83 cents, pegged to the peer average FY18 P/E ratio of 26.8 times.


Aoxin takes a big bite of China's buoyant dental market

SINGAPORE (Jan 31): Oral medicine specialist Dr Shao Yongxin has always been fascinated by the artistry and technical expertise involved in the practice of dentistry.

Broker's Calls

Ang Peng Tiam's suspension to remain key near-term overhang on TalkMed: CIMB

SINGAPORE (Jan 8): CIMB is maintaining its “hold” call on TalkMed Group with a lower target price of 68 cents from 92 cents previously, after cutting FY17-19F earnings per share (EPS) estimates by 18-21% to factor anticipated earnings losses from the

Ping An is now second largest shareholder of Fullerton Healthcare after $163.3 mil investment

SINGAPORE (Nov 28): Fullerton Healthcare Corporation, which deferred plans for an IPO last year, has received a significant investment of more than RMB800 million ($163.3 million) from Ping An Capital.

Broker's Calls

Robust growth momentum keeps Health Management at 'buy'

SINGAPORE (Nov 16): Maybank Kim Eng is maintaining its “buy” call on Health Management International (HMI) with a target price of 80 cents, after the group’s 1Q18 core earnings came in line with expectations to make up 27% of the research house’s